A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
about
Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationA therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationComparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantationProphylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantationIndications for platelet transfusion in patients with thrombocytopeniaOptimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials.Feasibility and usefulness of self-assessment of bleeding in patients with haematological malignancies, and the association between platelet count and bleeding.Platelet transfusions for patients with haematological malignancies: who needs them?The influence of bleeding on trigger changes for platelet transfusion in patients with chemotherapy-induced thrombocytopenia.The observation of bleeding complications in haemato-oncological patients: stringent watching, relevant reporting.Thromboelastography (TEG®) compared with total platelet count in thrombocytopenia haematological malignancy patients with bleeding: a pilot observational study.Evaluation of romiplostim for the treatment of secondary failure of platelet recovery among allogeneic hematopoietic stem cell transplant patients.[Therapy with blood products].Platelet and red blood cell utilization and transfusion independence in umbilical cord blood and allogeneic peripheral blood hematopoietic cell transplants.Utilization of blood and components in a tertiary care hospital.A study of the agreement between patient self-assessment and study personnel assessment of bleeding symptoms.A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantationThe challenges of measuring bleeding outcomes in clinical trials of platelet transfusions.Platelet transfusion: a systematic review of the clinical evidence.Advances in transfusion medicine: gastrointestinal bleeding.The association between platelet transfusion and idiopathic pneumonia syndrome is unaffected by platelet product type.Platelet Transfusion Thresholds Among Children Admitted to a Pediatric Intensive Care Unit.Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro.Impact of prophylactic platelet transfusions on bleeding events in patients with hematologic malignancies: a subgroup analysis of a randomized trial.The role of thromboelastography in predicting hemorrhage risk in patients with leukemia.Thrombocytopenia and bleeding in myelosuppressed transfusion-dependent patients: a simulation study exploring underlying mechanisms.
P2860
Q24186359-06801735-8567-45C8-9ADF-B31F6EE37963Q24186913-1D00D056-DCC1-4DBE-8507-EB9EB57E1CEAQ24187751-F1A27ED5-996C-4A08-AF44-1DDD0A46A82BQ24197779-F179D545-C43A-4AA1-AAB4-966CD2BD8DDCQ27023734-D45FB8A6-01E7-49C0-8091-1E9C152A05A1Q30248755-693755B2-0418-4D66-A3A6-6F0C17DC6B66Q33371442-28FE62E1-7126-42B0-938D-E26811366269Q33395509-B6852979-B596-474B-AF74-FB62DBDCFDD8Q33401634-32520714-29D4-4042-8E66-E422DF6F27E0Q33403659-B276429F-5B3A-440E-86A4-AB1773887185Q33424052-23747103-6F92-433F-ABA8-C3B95C4A9606Q33426772-8686EA3B-08AA-42C6-8D5D-61C586CBAC0CQ33429614-F44806E7-0623-473B-8AB7-80E1ECF77544Q34440672-8FB3FEFA-A7D0-4036-A57E-0F50C218B12FQ36263778-762D0D77-17C5-4672-9850-C2C938DED6F5Q36640496-40E32504-8A75-4C65-8E93-34BC72FCC5F5Q36941032-04ACA31C-46CB-4187-8822-E4B2F1BCD213Q38073018-AC07FD08-F596-4474-97F5-C1380B7CAC18Q38267183-466907C2-B4AA-492F-B9DE-4D1AD9013D35Q39453949-05C04E04-CE7D-44A8-9D0C-4B14FE0E475CQ41264625-F323D026-33E9-4FCE-B2E0-369A1FD9AFBCQ47241256-2F44DF9B-0A73-4BD0-A272-8C455405615CQ49061820-35AB0652-0462-485C-9C95-B171BB2603CAQ51742200-D73309D1-408A-4257-8998-7ADC768D67B6Q52622931-06A6CE99-C0E8-44B4-9B3B-05CDD4523FCFQ55421841-4DD060B4-8E91-414E-A863-256A3EE1121F
P2860
A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10
@nl
A prospective randomized trial ...... or cell transplant recipients.
@en
type
label
A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10
@nl
A prospective randomized trial ...... or cell transplant recipients.
@en
prefLabel
A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10
@nl
A prospective randomized trial ...... or cell transplant recipients.
@en
P2093
P2860
P1433
P1476
A prospective randomized trial ...... or cell transplant recipients.
@en
P2093
Agneta Shanwell
Beatrice Diedrich
Britt-Marie Svahn
Mats Remberger
Olle Ringdén
P2860
P304
P356
10.1111/J.1537-2995.2005.04157.X
P577
2005-07-01T00:00:00Z